A guide to finding and checking care
Sermorelin clinic directory: a guide to checking care
Looking for clinic names? This site offers a guide to finding and checking care, with questions to ask before agreeing to treatment.
Find care you can question.
Use this guide to find care and ask how it works. It is not a provider directory and offers neither treatment nor clinic listings.
Begin the care checkRead the US status first
What are you being offered?
Sermorelin copies part of a hormone, a body signal that prompts growth hormone release from a small gland beneath the brain.
Growth hormone is a body signal that helps children grow.
In small studies of older adults, hormone levels rose but body fat did not change in the studies that measured it.
Ask what change in your daily life the treatment is meant to bring, and what research supports that goal.
The Food and Drug Administration, or FDA, handles reviews of medicines in the US.
No sermorelin product with FDA approval is on the US market as of September 28, 2026.
A useful opening question is: what problem is this meant to treat, and why is it being offered to me?
A name is only the start.
For a visit in person or online, ask who will assess your health. Get the doctor’s or other health professional’s name and job title, then ask who makes the medicine.
With telehealth, care takes place through a video call, a phone call or messages online. Keep the same questions for a visit in a room.
Still weighing it up?
It is fine to arrive with questions rather than a decision. Ask for the reason for treatment, the research behind it and the plan for checking progress.
Bring a question sheetSources behind this chapter
- Prakash and Goa: review of sermorelin
- FDA review of why sermorelin (Geref) left the market
- Corpas and colleagues: study in older men
- Vittone and colleagues: study in older men
- Khorram and colleagues: study of a changed version of the hormone
- FDA application records for sermorelin
- US search for sermorelin drug information sheets